231 related articles for article (PubMed ID: 26231488)
1. Assessment of DNA Integrity, Applications for Cancer Research.
Zonta E; Nizard P; Taly V
Adv Clin Chem; 2015; 70():197-246. PubMed ID: 26231488
[TBL] [Abstract][Full Text] [Related]
2. Circulating Plasma Tumor DNA.
Parsons HA; Beaver JA; Park BH
Adv Exp Med Biol; 2016; 882():259-76. PubMed ID: 26987539
[TBL] [Abstract][Full Text] [Related]
3. Quality control of ion torrent sequencing library.
Pop LA; Puscas E; Pileczki V; Cojocneanu-Petric R; Braicu C; Achimas-Cadariu P; Berindan-Neagoe I
Cancer Biomark; 2014; 14(2-3):93-101. PubMed ID: 24878810
[TBL] [Abstract][Full Text] [Related]
4. Role of Circulating Cell-Free DNA in Cancers.
Aarthy R; Mani S; Velusami S; Sundarsingh S; Rajkumar T
Mol Diagn Ther; 2015 Dec; 19(6):339-50. PubMed ID: 26400814
[TBL] [Abstract][Full Text] [Related]
5. Cell-Free DNA Integrity: Applications.
Ravaioli S
Methods Mol Biol; 2019; 1909():77-83. PubMed ID: 30580423
[TBL] [Abstract][Full Text] [Related]
6. Potential clinical utility of ultrasensitive circulating tumor DNA detection with CAPP-Seq.
Bratman SV; Newman AM; Alizadeh AA; Diehn M
Expert Rev Mol Diagn; 2015 Jun; 15(6):715-9. PubMed ID: 25773944
[TBL] [Abstract][Full Text] [Related]
7. Cell-free DNA as a novel marker in cancer therapy.
Kato S; Janku F
Biomark Med; 2015; 9(7):703-12. PubMed ID: 26174844
[TBL] [Abstract][Full Text] [Related]
8. Circulating cell-free DNA integrity as a diagnostic and prognostic marker for breast and prostate cancers.
Arko-Boham B; Aryee NA; Blay RM; Owusu EDA; Tagoe EA; Doris Shackie ES; Debrah AB; Adu-Aryee NA
Cancer Genet; 2019 Jun; 235-236():65-71. PubMed ID: 31105051
[TBL] [Abstract][Full Text] [Related]
9. Blood Worth Bottling: Circulating Tumor DNA as a Cancer Biomarker.
Christie EL; Dawson SJ; Bowtell DD
Cancer Res; 2016 Oct; 76(19):5590-5591. PubMed ID: 27698187
[No Abstract] [Full Text] [Related]
10. Circulating tumor cells and circulating tumor DNA: What surgical oncologists need to know?
Cabel L; Proudhon C; Mariani P; Tzanis D; Beinse G; Bieche I; Pierga JY; Bidard FC
Eur J Surg Oncol; 2017 May; 43(5):949-962. PubMed ID: 28185687
[TBL] [Abstract][Full Text] [Related]
11. Dynamic sequencing of circulating tumor DNA: novel noninvasive cancer biomarker.
Lianos GD; Mangano A; Kouraklis G; Roukos DH
Biomark Med; 2014; 8(5):629-32. PubMed ID: 25123031
[No Abstract] [Full Text] [Related]
12. Liquid biopsy: will it be the 'magic tool' for monitoring response of solid tumors to anticancer therapies?
Gingras I; Salgado R; Ignatiadis M
Curr Opin Oncol; 2015 Nov; 27(6):560-7. PubMed ID: 26335664
[TBL] [Abstract][Full Text] [Related]
13. Microfluidic devices for the isolation of circulating rare cells: a focus on affinity-based, dielectrophoresis, and hydrophoresis.
Hyun KA; Jung HI
Electrophoresis; 2013 Apr; 34(7):1028-41. PubMed ID: 23436295
[TBL] [Abstract][Full Text] [Related]
14. Serum DNA integrity index as a potential molecular biomarker in endometrial cancer.
Vizza E; Corrado G; De Angeli M; Carosi M; Mancini E; Baiocco E; Chiofalo B; Patrizi L; Zampa A; Piaggio G; Cicchillitti L
J Exp Clin Cancer Res; 2018 Jan; 37(1):16. PubMed ID: 29382392
[TBL] [Abstract][Full Text] [Related]
15. Advances in Circulating Tumor DNA Analysis.
Perakis S; Auer M; Belic J; Heitzer E
Adv Clin Chem; 2017; 80():73-153. PubMed ID: 28431643
[TBL] [Abstract][Full Text] [Related]
16. Application and optimization of minimally invasive cell-free DNA techniques in oncogenomics.
Kumar M; Choudhury Y; Ghosh SK; Mondal R
Tumour Biol; 2018 Feb; 40(2):1010428318760342. PubMed ID: 29484962
[TBL] [Abstract][Full Text] [Related]
17. Label-free screening of single biomolecules through resistive pulse sensing technology for precision medicine applications.
Harrer S; Kim SC; Schieber C; Kannam S; Gunn N; Moore S; Scott D; Bathgate R; Skafidas S; Wagner JM
Nanotechnology; 2015 May; 26(18):182502. PubMed ID: 25875197
[TBL] [Abstract][Full Text] [Related]
18. Analysis of methylated circulating DNA in cancer patients' blood.
Sunami E; Vu AT; Nguyen SL; Hoon DS
Methods Mol Biol; 2009; 507():349-56. PubMed ID: 18987826
[TBL] [Abstract][Full Text] [Related]
19. Mutation-based detection and monitoring of cell-free tumor DNA in peripheral blood of cancer patients.
Benesova L; Belsanova B; Suchanek S; Kopeckova M; Minarikova P; Lipska L; Levy M; Visokai V; Zavoral M; Minarik M
Anal Biochem; 2013 Feb; 433(2):227-34. PubMed ID: 22750103
[TBL] [Abstract][Full Text] [Related]
20. Assessment of circulating serum DNA integrity in colorectal cancer patients.
Yörüker EE; Özgür E; Keskin M; Dalay N; Holdenrieder S; Gezer U
Anticancer Res; 2015 Apr; 35(4):2435-40. PubMed ID: 25862911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
